We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Sustained-Release Cetylpyridinium Chloride Varnish on Streptococcus Mutans and Lactobacillus in Orthodontic Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2006 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00416286
First Posted: December 27, 2006
Last Update Posted: July 25, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hadassah Medical Organization
  Purpose
The purpose of the study is to was to evaluate the anti bacterial efficacy of sustain-release Cetylpyridinium chloride varnish on orthodontic patients.

Condition Phase
Healthy Phase 1

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Phase 1: To Evaluate the Antibacterial Efficacy of Sustained Release Cetylpyridinium Chloride Varnish in Orthodontic Patients

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 30
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Exclusion Criteria:

  • Children under 12y old
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00416286


Contacts
Contact: Doron Harari, DMD 972-2-6776169 dharari@cc.huji.ac.il

Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Doron Harari, DMD Orthodontic department, Dental school Hadassah Ein Kerem
  More Information

ClinicalTrials.gov Identifier: NCT00416286     History of Changes
Other Study ID Numbers: 26-23.12.05-HMO-CTIL
26-23.12.05
code: 1371
First Submitted: December 25, 2006
First Posted: December 27, 2006
Last Update Posted: July 25, 2007
Last Verified: December 2006

Keywords provided by Hadassah Medical Organization:
Cetylpyridinium chlorid
Sustained release
orthodontic patients
streptococcus mutans
Lactobacillus
Rate of bacterial load in saliva of orthodontic patients

Additional relevant MeSH terms:
Cetylpyridinium
Anti-Infective Agents, Local
Anti-Infective Agents